Germany Women’s Health Market Size & Outlook, 2023-2030
Germany women’s health market, 2018-2030 (US$M)
Related Markets
Germany women’s health market highlights
- The Germany women’s health market generated a revenue of USD 2,314.8 million in 2023 and is expected to reach USD 3,405.2 million by 2030.
- The Germany market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 2,314.8 million |
| Market revenue in 2030 | USD 3,405.2 million |
| Growth rate | 5.7% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, Germany accounted for 5.2% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany women’s health market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 3,031.4 million by 2030.
Contraceptives was the largest segment with a revenue share of 30.28% in 2023. Horizon Databook has segmented the Germany women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank, in 2022, the population of women aged 65 and above was around 10.5 million. Women at this age are prone to postmenopausal problems, such as osteoporosis. Moreover, according to the UN population data, 1 in every 20 Germans is aged above 80, which is expected to increase to 6 by 2050.
The increasing population of women aged 65 and above is responsible for the growing incidence of menopause-related conditions, such as hot flashes, as the symptoms can last for decades. This creates opportunities for market players to target older women.
The growing population of elderly women and increasing usage of contraceptives are some of the key factors anticipated to drive the market in Germany. Key market players have undertaken various strategic initiatives to expand their businesses in the country in the past few years.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany women’s health market size, by application, 2018-2030 (US$M)
Germany Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
